The mechanism may be through increasing the expression of estrogen receptor β (ERβ) in renal cell carcinoma, and the expression of ERβ is closely related to the clinical prognosis and immunotherapy response of renal cell carcinoma [32]. This evidence concerns the gene ESR2 and hereditary clear cell renal cell carcinoma.